NDC 63323-398-41 - Azithromycin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-398
- Requested NDC
- 63323-398-41
- Package NDCs from labels
- 63323-398-01, 63323-398-10, 63323-398-41, 63323-398-14, 63323-398-12
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2024-10-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Azithromycin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-10-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Azithromycin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-10-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Azithromycin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-10-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-398-01 | Azithromycin | 5 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 5 | 8 | |
| 63323-398-10 | Azithromycin | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | 8 | |
| 63323-398-14 | Azithromycin | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | 4 | |
| 63323-398-41 | Azithromycin | 5 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 5 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-398 | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 8 | Current NDC, Legacy NDC, 2 package rows | 20241018_b69917c0-95d5-4b29-b0e3-07054a4fd79f.zip |
| 63323-398 | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20241018_9ad099d5-5c57-4855-98a4-e03fb4629dbf.zip |
| 63323-398 | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 3 | Current NDC, Legacy NDC | 20241018_62f6f327-3fef-49f0-ae90-078356d002b5.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-398-01 | EA - Each | 63323-398 | ee95010a-cd05-45d8-a81a-e229af268f31 | 1 | 2024-04-05 |
| 63323-398-10 | EA - Each | 63323-398 | 70ccab4e-3d2b-47c5-8bea-1693038f96ae | 1 | 2012-07-24 |
| 63323-398-12 | EA - Each | 63323-398 | c7f52582-24e3-4fdb-910e-7e1cef7c48da | 1 | 2014-02-04 |
| 63323-398-14 | EA - Each | 63323-398 | a7f887ec-a04b-4a90-bc10-ef967647beb5 | 1 | 2014-08-01 |
| 63323-398-41 | EA - Each | 63323-398 | 09dabf8c-0f7b-4cf3-8b9c-d99debb0d5dd | 1 | 2024-04-05 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PaxLyte | LEUCOVORIN, FOLIC ACID, LEVOMEFOLATE MAGNESIUM, FERROUS CYSTEINE GLYCINATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, PHOSPHATIDYL SERINE, PYRIDOXAL 5-PHOSPHATE, FLAVIN ADENINE DINUCLEOTIDE, NADH, COBAMAMIDE, COCARBOXYLASE (THIAMINE PYROPHOSPHATE), MAGNESIUM ASCORBATE, ZINC ASCORBATE, MAGNESIUM L-THREONATE AND BETAINE CAPSULE | Jaymac Pharmaceuticals | f520b130-61b3-443e-aaf6-91e094e7a334 | 2025-12-08 | Warnings, Adverse reactions | 2968PHW8QP |
| Alka-Seltzer Heartburn | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | Bayer HealthCare LLC. | 55158e50-0327-2043-e054-00144ff8d46c | 2025-12-04 | Warnings | 2968PHW8QP |
| Alka-Seltzer Gold | ALKA-SELTZER GOLD | Bayer HealthCare LLC. | 0824bedb-413b-2fa0-e054-00144ff88e88 | 2025-12-04 | Warnings | 2968PHW8QP |
| AZITHROMYCIN | AZITHROMYCIN | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 714f6f55-278a-4fcf-8d4e-2ad9b43623a3 | 2025-11-20 | Warnings, Adverse reactions | JTE4MNN1MD |
| Earthmed Soothe Chewable Orange | CITRIC ACID | Earthmed LLC | 439543fe-ceb9-4c5c-e063-6294a90a9b70 | 2025-11-14 | Warnings | 2968PHW8QP |
| AZITHROMYCIN | AZITHROMYCIN | NuCare Pharmaceuticals, Inc. | 3f7c7421-411d-c04e-e063-6394a90a4aa0 | 2025-09-23 | Warnings, Adverse reactions | JTE4MNN1MD |
| Medique Medi Seltzer | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Unifirst First Aid Corporation | 528da9d9-2a52-4c16-b7b2-61b3eee1abea | 2025-08-19 | Warnings | 2968PHW8QP |
| Azithromycin | AZITHROMYCIN MONOHYDRATE | Sagent Pharmaceuticals | cefbce3f-3e6c-4659-abd7-3ec3e8227737 | 2025-07-28 | Warnings, Adverse reactions | 1668238 JTE4MNN1MD |
| Phexx | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | Evofem, Inc. | 14b01a15-9b47-4be3-bb2e-a2010eab429e | 2025-05-02 | Warnings, Adverse reactions | 2968PHW8QP |
| Tricitrates | TRICITRATES | Chartwell RX, LLC | 2a80ea6b-6334-4c33-a35e-a5cb2939fbcb | 2025-04-28 | Warnings, Adverse reactions | 2968PHW8QP |
| Potassium Citrate and Citric Acid | POTASSIUM CITRATE AND CITRIC ACID | Chartwell RX, LLC | 978a5a9d-f0ca-4308-a84b-3b132263bbb8 | 2025-04-09 | Warnings, Adverse reactions | 2968PHW8QP |
| Alka-Seltzer Heartburn Relief Lemon Lime | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | Bayer Healthcare LLC | cc21af24-9a5b-6831-e053-2a95a90a0af4 | 2025-04-01 | Warnings | 2968PHW8QP |
| Alka-Seltzer Heartburn Relief Extra Strength | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | Bayer Healthcare LLC | dc1641f8-54c2-0d86-e053-2995a90a1dce | 2025-03-11 | Warnings | 2968PHW8QP |
| Azithromycin | AZITHROMYCIN MONOHYDRATE | Athenex Pharmaceutical Division, LLC. | 610a34ea-6aa7-4b94-a85a-ff16ca537d03 | 2025-01-28 | Warnings, Adverse reactions | 1668238 JTE4MNN1MD |
| Azithromycin | AZITHROMYCIN MONOHYDRATE | Athenex Pharmaceutical Division, LLC. | 324330c5-20fe-4b22-adf2-14a6e91e71ef | 2025-01-28 | Warnings, Adverse reactions | 1668238 JTE4MNN1MD |
| Anticoagulant Citrate Dextrose A ACD-A | ANTICOAGULANT CITRATE DEXTROSE A ACD-A | Arteriocyte Medical Systems, Inc. | b850deac-161f-4bb0-ac7f-bceac2a230c0 | 2025-01-23 | 2968PHW8QP | |
| ACD A | DEXTROSE MONOHYDRATE, SODIUM CITRATE, AND CITRIC ACID MONOHYDRATE | Terumo BCT Ltd | 570770de-9b48-4fc1-a1ee-06002ca9504f | 2025-01-22 | 2968PHW8QP | |
| AZITHROMYCIN | AZITHROMYCIN | DirectRx | d564d91e-3039-c120-e053-2995a90ae6db | 2025-01-21 | Warnings, Adverse reactions | JTE4MNN1MD |
| Anticoagulant Citrate Dextrose (ACD-A) | DEXTROSE MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM, AND CITRIC ACID MONOHYDRATE | Terumo BCT, Ltd | 0130d7c8-d067-4528-beb7-166559c33be9 | 2025-01-21 | Warnings, Adverse reactions | 2968PHW8QP |
| Soothe Chewable | CITRIC ACID | Carolina Cannabis Creations LLC | 04a27a71-b7b2-12aa-e063-6294a90a312f | 2025-01-15 | Warnings | 2968PHW8QP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.